DE602004015254D1 - Hiv-inhibierende1,2,4-triazine - Google Patents

Hiv-inhibierende1,2,4-triazine

Info

Publication number
DE602004015254D1
DE602004015254D1 DE602004015254T DE602004015254T DE602004015254D1 DE 602004015254 D1 DE602004015254 D1 DE 602004015254D1 DE 602004015254 T DE602004015254 T DE 602004015254T DE 602004015254 T DE602004015254 T DE 602004015254T DE 602004015254 D1 DE602004015254 D1 DE 602004015254D1
Authority
DE
Germany
Prior art keywords
hiv
triazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004015254T
Other languages
English (en)
Inventor
Paulus Joannes Lewi
Paul Adriaan Jan Janssen
Jonge Marc Rene De
Lucien Maria Henricus Koymans
Hendrik Maarten Vinkers
Frederik Frans Desire Daeyaert
Jan Heeres
Ruben Gerardus George Leenders
Georges Joseph Corne Hoornaert
Amuri Kilonda
Donald W Janssen Phar Ludovici
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of DE602004015254D1 publication Critical patent/DE602004015254D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
DE602004015254T 2003-02-07 2004-02-05 Hiv-inhibierende1,2,4-triazine Expired - Lifetime DE602004015254D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP0301289 2003-02-07
PCT/EP2004/050084 WO2004074266A1 (en) 2003-02-07 2004-02-05 Hiv inhibiting 1,2,4-triazines

Publications (1)

Publication Number Publication Date
DE602004015254D1 true DE602004015254D1 (de) 2008-09-04

Family

ID=32892827

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004015254T Expired - Lifetime DE602004015254D1 (de) 2003-02-07 2004-02-05 Hiv-inhibierende1,2,4-triazine

Country Status (20)

Country Link
US (1) US7585861B2 (de)
EP (1) EP1597242B1 (de)
JP (1) JP4783725B2 (de)
KR (1) KR20050105190A (de)
CN (2) CN102503903A (de)
AP (1) AP2005003365A0 (de)
AT (1) ATE402152T1 (de)
AU (1) AU2004213173B2 (de)
BR (1) BRPI0407306A (de)
CA (1) CA2513123C (de)
DE (1) DE602004015254D1 (de)
EA (1) EA010379B1 (de)
ES (1) ES2311146T3 (de)
HR (1) HRP20050690A2 (de)
IL (1) IL170120A (de)
MX (1) MXPA05008368A (de)
NO (1) NO20054127L (de)
PL (1) PL232814B1 (de)
WO (1) WO2004074266A1 (de)
ZA (1) ZA200506254B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005231507B2 (en) 2004-04-08 2012-03-01 Targegen, Inc. Benzotriazine inhibitors of kinases
RU2401833C2 (ru) * 2004-08-10 2010-10-20 Янссен Фармацевтика Н.В. Производные 1, 2, 4-триазин-6-она, ингибирующие вич
JP5275628B2 (ja) 2004-08-25 2013-08-28 ターゲジェン インコーポレーティッド 複素環式化合物および使用方法
MX2007003321A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como agentes terapeuticos.
CN101083994A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其用作硬脂酰CoA去饱和酶抑制剂的用途
US7951805B2 (en) 2004-09-20 2011-05-31 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
WO2006034315A2 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
CA2580845A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
AR051202A1 (es) 2004-09-20 2006-12-27 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
AU2005329423A1 (en) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
BRPI0611187A2 (pt) 2005-06-03 2010-08-24 Xenon Pharmaceuticals Inc derivados aminotiazàis como inibidores da estearoil-coa desaturase humana
US8604042B2 (en) 2005-11-01 2013-12-10 Targegen, Inc. Bi-aryl meta-pyrimidine inhibitors of kinases
DK1951684T3 (en) 2005-11-01 2016-10-24 Targegen Inc BIARYLMETAPYRIMIDIN kinase inhibitors
US8133900B2 (en) 2005-11-01 2012-03-13 Targegen, Inc. Use of bi-aryl meta-pyrimidine inhibitors of kinases
MX2009008253A (es) * 2007-01-31 2009-10-12 Vertex Pharma Derivados de 2-aminopiridina utiles como inhibidores de cinasa.
CA2723961C (en) 2008-05-21 2017-03-21 Ariad Pharmaceuticals, Inc. Phosphorous derivatives as kinase inhibitors
JP5631310B2 (ja) 2008-07-23 2014-11-26 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated 三環式ピラゾロピリジンキナーゼ阻害剤
AU2009274011B2 (en) 2008-07-23 2014-12-18 Vertex Pharmaceuticals Incorporated Pyrazolopyridine kinase inhibitors
US8569337B2 (en) 2008-07-23 2013-10-29 Vertex Pharmaceuticals Incorporated Tri-cyclic pyrazolopyridine kinase inhibitors
MX2011001319A (es) 2008-08-06 2011-04-05 Vertex Pharma Inhibidores de aminopiridina cinasa.
CN102459259A (zh) 2009-05-06 2012-05-16 沃泰克斯药物股份有限公司 吡唑并吡啶类
MX2012008644A (es) 2010-01-27 2012-11-23 Vertex Pharma Inhibidores de cinasa de pirazolopiridinas.
CN102869664A (zh) 2010-01-27 2013-01-09 沃泰克斯药物股份有限公司 吡唑并嘧啶类激酶抑制剂
WO2011094288A1 (en) 2010-01-27 2011-08-04 Vertex Pharmaceuticals Incorporated Pyrazolopyrazine kinase inhibitors
WO2012060847A1 (en) 2010-11-07 2012-05-10 Targegen, Inc. Compositions and methods for treating myelofibrosis
WO2016044445A2 (en) 2014-09-17 2016-03-24 Ironwood Pharmaceuticals, Inc. sGC STIMULATORS
SG10202110874TA (en) 2016-06-07 2021-11-29 Jacobio Pharmaceuticals Co Ltd Novel heterocyclic derivatives useful as shp2 inhibitors
EA201992253A1 (ru) 2017-03-23 2020-03-31 Джакобио Фармасьютикалс Ко., Лтд. Новые гетероциклические производные, применимые в качестве ингибиторов shp2
WO2021071984A1 (en) * 2019-10-08 2021-04-15 Skyhawk Therapeutics, Inc. Compounds for modulating splicing
CN114980887A (zh) 2019-12-20 2022-08-30 特纳亚治疗股份有限公司 氟代烷基-噁二唑及其用途
CN111333543B (zh) * 2020-04-17 2022-09-16 武汉工程大学 一种利匹韦林中间体的合成方法
CN115745848A (zh) * 2022-12-07 2023-03-07 上海优合生物科技有限公司 一种氨基胍的加工合成工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459731A (en) 1966-12-16 1969-08-05 Corn Products Co Cyclodextrin polyethers and their production
HUP9900730A3 (en) 1995-11-23 2001-04-28 Janssen Pharmaceutica Nv Solid mixtures of cyclodextrins prepared via melt-extrusion
NO311614B1 (no) * 1996-10-01 2001-12-17 Janssen Pharmaceutica Nv Substituerte diamino-1,3,5-triazinderivater
JP3440263B2 (ja) 1998-03-27 2003-08-25 エルジー・ライフ・サイエンシーズ・リミテッド 新規アスコルビン酸誘導体及びその調製方法
EP0945447A1 (de) * 1998-03-27 1999-09-29 Janssen Pharmaceutica N.V. Trisubstituierte 1,3,5-Triazinderivate zur Behandlung von HIV Infektionen
WO1999050250A1 (en) * 1998-03-27 1999-10-07 Janssen Pharmaceutica N.V. Hiv inhibiting pyrimidine derivatives
OA11674A (en) * 1998-11-10 2005-01-12 Janssen Pharmaceutica Nv HIV Replication inhibiting pyrimidines.
NZ510919A (en) * 1998-11-10 2003-11-28 Janssen Pharmaceutica Nv 2,4-disubstituted triazine derivatives
ES2542326T3 (es) * 2000-05-08 2015-08-04 Janssen Pharmaceutica Nv Inhibidores de la replicación del VIH
WO2002078708A1 (en) 2001-03-15 2002-10-10 Janssen Pharmaceutica N.V. Hiv inhibiting pyrazinone derivatives
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز

Also Published As

Publication number Publication date
JP4783725B2 (ja) 2011-09-28
EP1597242B1 (de) 2008-07-23
EA010379B1 (ru) 2008-08-29
US20070037811A1 (en) 2007-02-15
CA2513123A1 (en) 2004-09-02
EA200501268A1 (ru) 2006-02-24
EP1597242A1 (de) 2005-11-23
CN1747941A (zh) 2006-03-15
NO20054127L (no) 2005-09-05
ATE402152T1 (de) 2008-08-15
ZA200506254B (en) 2008-02-27
KR20050105190A (ko) 2005-11-03
MXPA05008368A (es) 2005-11-04
HRP20050690A2 (en) 2006-08-31
WO2004074266A8 (en) 2004-11-11
US7585861B2 (en) 2009-09-08
JP2006516983A (ja) 2006-07-13
CN102503903A (zh) 2012-06-20
ES2311146T3 (es) 2009-02-01
CA2513123C (en) 2013-04-23
IL170120A (en) 2013-04-30
AP2005003365A0 (en) 2005-09-30
AU2004213173B2 (en) 2010-07-29
PL378107A1 (pl) 2006-03-06
WO2004074266A1 (en) 2004-09-02
PL232814B1 (pl) 2019-07-31
BRPI0407306A (pt) 2006-02-21
AU2004213173A1 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
DE602004015254D1 (de) Hiv-inhibierende1,2,4-triazine
CY2014041I1 (el) 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
MX267068B (es) Derivados simetricos de triazina.
DE602004006169D1 (de) Substituierte 8'-pyri(mi)dinyl-dihydrospiro-äcycloalkylaminü-pyrimidoä1,2aüpyrimidin-6-onderivate
DK1471065T3 (da) Hidtil ukendt 1,2,4-triazolforbindelse
DE602004024770D1 (de) Substituierte 8-perfluoro-6,7,8,9-tetrahydropyrimido-(1,2a) pyrimidin-4-on derivate
DE60305332D1 (de) IMIDAZOi1,2-AöPYRIDINE
NO20051500D0 (no) Substituerte heterocyklylpyrimidiner.
ES2403141T8 (es) Derivado de 2,4-diamino-1,3,5-triazina
FI20020881A (fi) Iskulaite
ITMI20032170A1 (it) Tagliacimosse.
NO20044405L (no) Neurotensinaktive 2,3-diaryl-pyrazolidin derivater
ES1052590Y (es) Quiosco-consigna.
SE0301847D0 (sv) Novel 3,3-Diphenylpropylamines
ES1057516Y (es) Pieza rodapie mejorada.
ITMI20032097A1 (it) Interlacciatore.
ES1048344Y (es) Mochila perfeccionada.
ES1049974Y (es) Mochila perfeccionada.
ES1053097Y (es) Envase-expositor mejorado.
ES1052724Y (es) Mochila.
ES1051515Y (es) Estuche perfeccionado.
FI5602U1 (fi) Marjasose
ES1048458Y (es) Estuche perfeccionado.
ES1055719Y (es) Estuche perfeccionado.
ES1053039Y (es) Tendedero de fuelle mejorado.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition